Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy

Clinical Journal of Pain

Volumn 25, Issue 5, 2009, Pages 413-417

  Rivard, Patrick F ^a   Nugent, Andrea C ^a   Symons, Frank J ^b  

^a GILLETTE CHILDREN'S SPECIALTY HEALTHCARE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Botulinum toxin type A; Cerebral palsy; Pain; Spasticity

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ANALGESIA; ARTICLE; CEREBRAL PALSY; CHILD; CHILD PARENT RELATION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SPASTICITY; STANDARDIZATION; TREATMENT OUTCOME;

EID: 67649531952     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31819a6d07     Document Type: Article

References (14)

1. O'Brien CF. Treatment of spasticity with botulinum toxin. Clin J Pain. 2002;18:S182-S190.
2. Koman LA, Mooney JF, Smith BP, et al, BOTOX Study Group. Botulinum toxin type A neuromuscular blockage in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. J Pediatr Orthop. 2000;20:108-115.
3. Satila H, Lisalo T, Pietkiainen T, et al. Botulinum toxin treatment of spastic equinus in cerebral palsy: a randomized trial comparing two injection sites. Am J Phys Med Rehabil. 2005;84:355-365.
4. Pierson SH, Katz DI, Tarsy D. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil. 1996;77:717-721.
5. McKearnan KA, Kieckhefer GM, Engel JM, et al. Pain in children with cerebral palsy: a review. J Neurosci Nurs. 2004; 36:252-259.
6. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology. 1995;45: 712-717.
7. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry. 1995;58:232-235.
8. Snow BJ, Tsui JKC, Bhatt MH, et al. Treatment of spasticity with botulinum toxin: a double blind study. Ann Neurol. 1990; 28:512-515.
9. Wissel J, Muller J, Dressnandt J, et al. Management of spasticity associated pain with botulinum toxin A. J Pain Symp Manag. 2000;20:44-49.
10. Barwood S, Baillieu C, Boyd R, et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neuro. 2000;42:116-121.
11. Breau LM, Camfield CS, McGrath PJ, et al. The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med. 2003;157:1219-1226.
12. Tyler EJ, Jensen MP, Engel JM, et al. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil. 2002;83:236-239.
13. Breau LM, Camfield CS, McGrath PJ, et al. Risk factors for pain in children with severe cognitive impairments. Dev Med Child Neuro. 2004;46:364-371.
14. Broderick JE, Stone AA, Calvanese P, et al. Recalled pain ratings: a complex and poorly defined task. J. Pain. 2006;7: 142-149.